Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: Diagnostic performance and confidence of contrast-enhanced ultrasound

European Radiology

Volumn 17, Issue 3, 2007, Pages 650-661

  Bartolotta, Tommaso Vincenzo ^a,b   Taibbi, Adele ^a   Galia, Massimo ^a   Runza, Giuseppe ^a   Matranga, Domenica ^a   Midiri, Massimo ^a   Lagalla, Roberto ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

CEUS; Contrast media; Diagnosis; Liver; Neoplasms; Ultrasound (US)

Indexed keywords

GADOBENATE DIMEGLUMINE; IOMEPROL; SODIUM CHLORIDE; SONOVUE;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; IMAGE ANALYSIS; JOB PERFORMANCE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; RADIOLOGIST; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADENOMA, LIVER CELL; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CHOLANGIOCARCINOMA; CONTRAST MEDIA; FATTY LIVER; FEMALE; HEMANGIOMA; HUMANS; HYPERPLASIA; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; OBSERVER VARIATION; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE;

EID: 33846962162     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-006-0432-x     Document Type: Article

References (53)

1. Harvey CJ, Albrecht T (2001) Ultrasound of focal liver lesions. Eur Radiol 11(9):1578-1593
2. Konno K, Ishida H, Sato M, Komatsuda T, Ishida J, Naganuma H, Hamashima Y, Watanabe S (2001) Liver tumors in fatty liver: Difficulty in ultrasonographic interpretation. Abdom Imaging 26(5):487-491
3. Burns PN, Wilson SR, Simpson DH (2000) Pulse inversion imaging of liver blood flow: Improved method for characterizing focal masses with microbubble contrast. Invest Radiol 35(1):58-71
4. Burns PN, Hope Simpson D, Averkiou MA (2000) Nonlinear imaging. Ultrasound Med Biol 26(Suppl 1):19-22
5. Kim SH, Lee JM, Lee JY, Han JK, An SK, Han CJ, Lee KH, Hwang SS, Choi BI (2005) Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: Receiver operating characteristic analysis. Am J Roentgenol 184(4):1077-1084
6. Bartolotta TV, Midiri M, Scialpi M, Sciarrino E, Galia M, Lagalla R (2004) Focal nodular hyperplasia in normal and fatty liver: A qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 14(4):583-591
7. Schneider M, Arditi M, Barrau M,Brochot J, Broillet A,Ventrone R, Yan F (1995) BR1: A new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbes. Invest Radiol 30(8):451-457
8. von Herbay A, Vogt C, Willers R, Haussinger D (2004) Real-time imaging with the sonographic contrast agent SonoVue: Differentiation between benign and malignant hepatic lesions. J Ultrasound Med 23(12):1557-1568
9. Quaia E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L, Pozzi-Mucelli R (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: Diagnostic performance and confidence. Radiology 232(2):420-430
10. Bartolotta TV, Midiri M, Quaia E, Bertolotto M, Galia M, Cademartiri F,Lagalla R, Cardinale AE (2005) Benign focal liver lesions: Spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 15(8):1643-1649
11. Scatarige JC, Scott WW, Donovan PJ, Siegelman SS, Sanders RC (1984) Fatty infiltration of the liver: Ultrasonographic and computed tomographic correlation. J Ultrasound Med 3(1):9-14
12. Foley D, Jochem RJ (1991) Computed tomography. Focal and diffuse liver disease. Radiol Clin North Am 29(6):1213-1233
13. Levenson H, Greensite F, Hoefs J, Friloux L, Applegate G, Silva E, Kanel G, Buxton R (1991) Fatty infiltration of the liver: Quantification with phase-contrast MR imaging at 1.5 T vs biopsy. Am J Roentgenol 156(2):307-312
14. Colli A, Fraquelli M, Andreoletti M, Marino B, Zuccoli E, Conte D (2003) Severe liver fibrosis or cirrhosis: Accuracy of US for detection - analysis of 300 cases. Radiology 227(1):89-94
15. World Medical Association Declaration of Helsinki (1964) Ethical principles for medical research involving human subjects. Available at http://www.wma.net/e/policy/pdf/17c.pdf
16. Leen E, Angerson WJ, Yarmenitis S, Bongartz G, Blomley M, Del Maschio A, Summaria V, Maresca G, Pezzoli C, Llull JB (2002) Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 41(3):200-206
17. Couinaud C (1957) Le foie: Etudes anatomiques et chirurgicales. Masson & Cie, Paris, France, pp 9-12
18. Nino-Murcia M, Olcott EW, Jeffrey RB Jr, Lamm RL, Beaulieu CF, Jain KA (2000) Focal liver lesions: Pattern-based classification scheme for enhancement at arterial phase CT. Radiology 215(3):746-751
19. Horton KM, Bluemke DA, Hruban RH, Soyer P, Fishman EK (1999) CT and MR imaging of benign hepatic and biliary tumors. Radiographics 19(2):431-451
20. Ros PR, Menu Y, Vilgrain V et al (2001) Liver neoplasms and tumor-like conditions. Eur Radiol 11(Suppl 2):S145-S165
21. Ros PR (2000) Benign liver lesions. Eur Radiol 10(Suppl 2):S175-S184
22. Nicolau C, Vilana R, Catalá V, Bianchi L, Gilabert R, Garcia A, Bru C (2006) Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. Am J Roentgenol 186(1):158-167
23. Lin ZY, Wang LY, Wang JH, Lu SN, Chen SC, Chuang WL, Hsieh MY, Tsai JF, Chang WY (1997) Clinical utility of color Doppler sonography in the differentiation of hepatocellular carcinoma from metastases and hemangioma. J Ultrasound Med 16(1):51-58
24. Wang LY, Wang JH, Lin ZY, Yu ML, Lu SN, Chuang WL, Chen SC, Hseih MY, Tsai JF, Chang WY (1997) Hepatic focal nodular hyperplasia: Findings on color Doppler ultrasound. Abdom Imaging 22(2):178-181
25. Tanaka S, Ioka T, Oshikawa O, Hamada Y, Yoshioka F (2001) Dynamic sonography of hepatic tumors. Am J Roentgenol 177(4):799-805
26. Lee MG, Auh YH, Cho KS, Chung YH, Lee IC, Kang EM (1996) Color Doppler flow imaging of hepatocellular carcinomas. Comparison with metastatic tumors and hemangiomas by three-step grading for color hues. Clin Imaging 20(3):199-203
27. Hosten N, Puls R, Bechstein WO, Felix R (1999) Focal liver lesions: Doppler ultrasound. Eur Radiol 9(3):428-435
28. Bartolozzi C, Lencioni R, Paolicchi A, Moretti M, Armillotta N, Pinto F (1997) Differentiation of hepatocellular adenoma and focal nodular hyperplasia of the liver: Comparison of power Doppler imaging and conventional color Doppler sonography. Eur Radiol 7(9):1410-1415
29. Obuchowski NA (2003) Receiver operating characteristic curves and their use in radiology. Radiology 229(1):3-8
30. Karhunen PJ (1986) Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 39(2):183-188
31. van Erkel AR, Pijl ME, van den Berg-Huysmans AA, Wasser MN, van de Velde CJ, Bloem JL (2002) Hepatic metastases in patients with colorectal cancer: Relationship between size of metastases, standard of reference, and detection rates. Radiology 224(2):404-409
32. Dill-Macky MJ, Burns PN, Khalili K, Wilson SR (2002) Focal hepatic masses: Enhancement patterns with SH U 508A and pulse-inversion US. Radiology 222(1):95-102
33. Bertolotto M, Dalla Palma L, Quaia E, Locatelli M (2000) Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: Preliminary results. Eur Radiol 10(9):1369-1376
34. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X (2000) Harmonic hepatic US with microbubble contrast agent: Initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 215(1):153-161
35. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG (2000) Hepatic tumors: Contrast agent-enhancement patterns with Pulse-Inversion harmonic US. Radiology 216(2):411-417
36. Von Herbay A, Vogt C, Haussinger D (2002) Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions. J Ultrasound Med 21(11):1191-2000
37. Nicolau C, Catala V, Bru C (2003) Characterization of focal liver lesions with contrast-enhanced ultrasound. Eur Radiol. 13(Suppl 3):70-78
38. Klein D, Jenett M, Gassel HJ, Sandstede J, Hahn D (2004) Quantitative dynamic contrast-enhanced sonography of hepatic tumors. Eur Radiol 14(6):1082-1091
39. Correas JM, Bridal L, Lesavre A, Mejean A, Claudon M, Helenon O (2001) Ultrasound contrast agents: Properties, principles of action, tolerance, and artifacts. Eur Radiol 11(8):1316-1328
40. Dalla Palma L, Bertolotto M (1999) Introduction to ultrasound contrast agents: Physics overview. Eur Radiol 9(Suppl 3):S338-S342
41. Schneider M (1999) SonoVue, a new ultrasound contrast agent. Eur Radiol 9(Suppl 3):S347-S348
42. Leen E (2001) The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Eur Radiol 11(Suppl 3):E27-E34
43. Lencioni R, Cioni D, Bartolozzi C (2002) Tissue harmonic and contrast-specific imaging: Back to gray scale in ultrasound. Eur Radiol 12(1):151-165
44. Solbiati L, Tonolini M, Cova L, Goldberg SN (2001) The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 11(Suppl 3):E15-E26
45. Albrecht T, Oldenburg A, Hohmann J, Skrok J, Hoffmann CW, Schettler S, Wolf KJ (2003) Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and SonoVue. Eur Radiol 13(Suppl 3):79-86
46. Brannigan M, Burns PN, Wilson SR (2004) Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics 24(4):921-935
47. Isozaki T, Numata K, Kiba T, Hara K, Morimoto M, Sakaguchi T, Sekihara H, Kubota T, Shimada H, Morizane T, Tanaka K (2003) Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 229(3):798-805
48. Nicolau C, Catala V, Vilana R, Gilabert R, Bianchi L, Sole M, Pages M, Bru C (2004) Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: Correlation with cellular differentiation. Eur Radiol 14(6):1092-1099
49. Nicolau C, Vilana R, Bru C (2004) The use of contrast-enhanced ultrasound in the management of the cirrhotic patient and for detection of HCC. Eur Radiol 14(Suppl 8):P63-P71
50. Bartolotta TV, Midiri M, Quaia E, Bertolotto M, Galia M, Cademartiri F, Lagalla R (2005) Liver haemangiomas undetermined at grey-scale ultrasound: Contrast-enhancement patterns with SonoVue and pulse-inversion US. Eur Radiol 15(4):685-693
51. Vilgrain V, Boulous L, Vullierme MP, Denys A, Terris B, Menu Y (2000) Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 20(2):379-397
52. von Herbay A, Vogt C, Haussinger D (2002) Late-phase pulse-inversion sonography using the contrast agent levovist: Differentiation between benign and malignant focal lesions of the liver. Am J Roentgenol 179(5):1273-1279
53. Mattrey RF, Kono Y (1999) Parenchymal enhancement on gray-scale in normal and pathologic tissues. Eur Radiol 9(Suppl 3):S359-S363